Protecting Kids' Hearts | Bladder Cancer | Sleep Problems, Cancer Information Highlights, 03/29/2023

National Cancer Institute sent this bulletin at 03/29/2023 10:55 AM EDT

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights

From the National Cancer Institute

Updating you about cancer causes, prevention, screening, treatment, coping, and more

New from NCI
Dexrazoxane Protects the Heart in Kids Being Treated for Cancer
		Doxorubicin is used to treat many types of childhood cancer, but it can damage the heart. Giving dexrazoxane (Zinecard) before each dose greatly reduces a child’s risk of treatment-related heart problems in adulthood.
Immunotherapy after Surgery Shows Benefits for Bladder Cancer
		Updated results from a large clinical trial confirm that, for some people with bladder cancer, receiving nivolumab (Opdivo) after surgery is an effective treatment.
Preventing Tumor Resistance to Targeted Therapy Many cancers that respond to targeted therapy will become resistant to the drugs in time. Researchers have learned more about how this resistance happens and how it may be disrupted.
PDQ Updates
Sleep Disorders Sleep problems are common in people with cancer. Learn more about sleep problems, their causes, and how they are treated.

Also of Interest
Childhood Bladder Cancer Bladder cancer is very rare in children. Learn about the symptoms and risk factors for childhood bladder cancer and how it is diagnosed and treated.
Contact Us for Help Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.